Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections. [electronic resource]
Producer: 20090803Description: 1107-14 p. digitalISSN:- 1542-6270
- Anti-Bacterial Agents -- adverse effects
- Clinical Trials as Topic
- Drug Resistance, Bacterial
- Folic Acid Antagonists -- adverse effects
- Gram-Positive Bacteria -- drug effects
- Gram-Positive Bacterial Infections -- drug therapy
- Humans
- Microbial Sensitivity Tests
- Pyrimidines -- adverse effects
- Tetrahydrofolate Dehydrogenase -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.